Why Pfizer's Future Looks Better in 2021

Keith Speights, The Motley Fool
·3 min read

In this Motley Fool Live video recorded on Jan. 13, 2021, healthcare and cannabis bureau chief Corinne Cardina and Fool.com writer Keith Speights discuss why Pfizer's future looks better in 2021. Corrine Cardina: Let's talk about its stock, so the biggest difference between the ones we've talked about Moderna, BioNTech: Pfizer has a dividend. Keith, you actually wrote an article about Pfizer as an investment, I'm going to post it in the chat for everyone, but can you give us the highlights of why Pfizer was so flat in 2020, despite this huge exciting news and what you think about it for 2021?